MAM
HOOK

Martingale Asset Management’s HOOKIPA Pharma HOOK Stock Holding History

Martingale Asset Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,501
Closed -$143K – 962
2020
Q3 		$143K Buy
+1,501
New +$153K ﹤0.01% 996

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Martingale Asset Management's HOOK Position: Q4 2020 in Review

Martingale Asset Management sold out of HOOKIPA Pharma (HOOK) in Q4 2020, closing a stake of 1,501 shares — an estimated $143K sold.

Martingale Asset Management first reported a position in HOOK in Q3 2020 and held it in 1 quarter. The position peaked at $143K in Q3 2020. 53 funds tracked by Wall St. Rank hold HOOK as of Q4 2020.

  • Martingale Asset Management reported no remaining HOOKIPA Pharma position as of Q4 2020 after selling out during the quarter.
  • Martingale Asset Management sold 1,501 HOOKIPA Pharma shares in Q4 2020, an estimated $143K.
  • Martingale Asset Management first reported a position in HOOKIPA Pharma in Q3 2020 and held it in 1 quarter.
  • Martingale Asset Management's HOOKIPA Pharma position peaked at $143K in Q3 2020.
  • 53 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2020.

Based on Martingale Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.